title: Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.
abstract: B-lymphocyte activation is a common characteristic of chronic hepatitis B virus (HBV) infection. B cell-activating factor (BAFF) plays a crucial role in the development and activation of B lymphocytes. This study investigated serum BAFF levels in 232 patients with different clinical diseases of chronic HBV infection [33 chronic asymptomatic HBV carrier (ASC), 53 chronic hepatitis (CH), 72 liver cirrhosis (LC), and 74 hepatocellular carcinoma (HCC)] and 61 gender- and age-matched healthy controls. Serum BAFF levels in HBV patients were significantly elevated compared with healthy controls (P<0.001). HCC patients had significantly higher levels of serum BAFF than ASC, CH, and LC (all P<0.001). Serum levels of BAFF in LC were significantly higher than in ASC (P<0.001) and CH (P=0.002). Serum level of BAFF was an independent variable associated with the presence of HCC in comparison with other disease groups in multivariate analysis. The area under receiver-operating characteristic curve (AUC) value of BAFF levels was 0.914 for HCC versus ASC, 0.825 for HCC versus CH, and 0.607 for HCC versus LC, respectively. The AUC value of BAFF levels was 0.854 for LC versus ASC and 0.748 for LC versus CH, respectively. The AUC value of BAFF (0.888) for HCC was higher than that of alpha-fetoprotein (0.776). We first demonstrate that serum BAFF levels in chronic HBV infection are elevated, correlated with clinical diseases, and could be used as a biomarker for indicating disease mechanisms, activity, and diagnosis.
authors.affiliation: 1 Department of Infectious Diseases, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University , Xi'an, China .
authors.forename: Cuiling
authors.initials: C
authors.lastname: Yang
authors.forename: Na
authors.initials: N
authors.lastname: Li
authors.forename: Yawen
authors.initials: Y
authors.lastname: Wang
authors.forename: Pingping
authors.initials: P
authors.lastname: Zhang
authors.forename: Qianqian
authors.initials: Q
authors.lastname: Zhu
authors.forename: Fang
authors.initials: F
authors.lastname: Li
authors.forename: Qunying
authors.initials: Q
authors.lastname: Han
authors.forename: Yi
authors.initials: Y
authors.lastname: Lv
authors.forename: Ling
authors.initials: L
authors.lastname: Yu
authors.forename: Ping
authors.initials: P
authors.lastname: Wei
authors.forename: Zhengwen
authors.initials: Z
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D058070:Asymptomatic Diseases; D053264:B-Cell Activating Factor / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000097:blood; D018450:Disease Progression; D005260:Female; D019694:Hepatitis B, Chronic / Q000097:blood / Q000175:diagnosis* / Q000276:immunology*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D055815:Young Adult
chemical_list: D053264:B-Cell Activating Factor; D015415:Biomarkers; C505719:TNFSF13B protein, human